At-home COVID test performance worsened after omicron emerged; Lancet commission slams global pandemic response
admin The performance of certain COVID-19 home-testing kits seems to have deteriorated after the omicron variant…
Read MoreHealth
WHO head offers upbeat view of state of pandemic: ‘The world has never been in a better position to end it’
The head of the World Health Organization offered an upbeat assessment of the state of…
Read MoreU.S. known COVID cases hold at lowest level since May, but infections are rising again in New York
U.S. known cases of COVID are continuing to ease and now stand at their lowest…
Read MoreU.S. COVID cases continue to decline, as Minnesota nurses stage 3-day walkout over pay and understaffing
U.S. known cases of COVID are continuing to ease and now stand at their lowest…
Read MoreCan nasal vaccines help prevent COVID-19 infections—or transmission?
The news earlier this week that China and India plan to roll out nasal vaccines…
Read MoreOmicron-targeting COVID boosters expected this week, but experts are worried there may be low uptake
The Food and Drug Administration is expected to authorize new COVID-19 booster shots this week…
Read MoreOnly 5 stocks in the S&P 500 ended in positive territory after Powell’s hawkish inflation speech
It took only a 10-minute speech from Federal Reserve Chairman Jerome Powell on Friday to…
Read MoreReport finds Americans with long COVID losing billions in wages, as Moderna sues Pfizer and BioNTech over mRNA patents
Some 16 million Americans of working age have long-term COVID and as many as 4…
Read MoreStudy finds Pfizer’s antiviral has little or even zero benefit for younger adults, and WHO says BA.5 omicron subvariant accounted for 74% of cases in latest week
Pfizer’s COVID antiviral Paxlovid appears to have little or no benefit for younger adults, although…
Read More
Weekend reads: This may cause the next financial crisis
The Federal Reserve invigorated the economy before and during the coronavirus pandemic by purchasing Treasury…
Read More